[Progress in diagnosis of and therapy for diabetic choreic movement and ballismus].
Nagai
Chiyoko
C
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001479:Basal Ganglia / Q000378:metabolism / Q000473:pathology; D002819:Chorea / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy; D020820:Dyskinesias / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D004745:Enkephalins; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D009474:Neurons / Q000473:pathology / Q000502:physiology; D013373:Substance P; D005680:gamma-Aminobutyric Acid
D018726:Anti-Dyskinesia Agents; D004745:Enkephalins; D007004:Hypoglycemic Agents; D013373:Substance P; D005680:gamma-Aminobutyric Acid; D006220:Haloperidol